Skip to main content
Log in

Quetiapine in Huntington’s disease: a first case report

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bogelman G, Hirschmann S, Modai I (2001) Olanzapine and Huntington’s disease. J Clin Psychopharmacol 21: 245–246

    Article  CAS  PubMed  Google Scholar 

  2. Dallocchio C, Buffa C, Tinelli C, Mazzarello P (1999) Effectiveness of risperidone in Huntington chorea patients. J Clin Psychopharmacol 19: 101–103

    Article  CAS  PubMed  Google Scholar 

  3. Dipple HC (1999) The use of olanzapine for movement disorder in Huntington’s disease: a first case report. J Neurol Neurosurg Psychiatry 67: 123–124

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Etchebehere EC, Lima MC, Passos W, Maciel Junior JA, Santos AO, Ramos CD, Camargo EE (1999) Brain SPECT imaging in Huntington’s disease before and after therapy with olanzapine. Case report. Arq Neuropsiquiatr 57: 863–866

    Article  CAS  PubMed  Google Scholar 

  5. Fava M (1997) Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 20: 427–451

    Article  CAS  PubMed  Google Scholar 

  6. Grove VE, Jr, Quintanilla J, DeVaney GT (2000) Improvement of Huntington’s disease with olanzapine and valproate. N Engl J Med 343: 973–974

    Article  PubMed  Google Scholar 

  7. Madhusoodanan S, Brenner R (1998) Use of risperidone in psychosis associated with Huntington’s disease. Am J Geriatr Psychiatry 6: 347–349

    CAS  PubMed  Google Scholar 

  8. Parsa MA, Szigethy E, Voci JM, Meltzer HY (1997) Risperidone in treatment of choreoathetosis of Huntington’s disease [letter]. J Clin Psychopharmacol 17: 134–135

    Article  CAS  PubMed  Google Scholar 

  9. Schott K, Ried S, Stevens I, Dichgans J (1989) Neuroleptically induced dystonia in Huntington’s disease: a case report. Eur Neurol 29: 39–40

    Article  CAS  PubMed  Google Scholar 

  10. Squitieri F, Cannella M, Piorcellini A, Brusa L, Simonelli M, Ruggieri S (2001) Short-term effects of olanzapine in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol 14: 69–72

    CAS  PubMed  Google Scholar 

  11. Stephenson CM, Bigliani V, Jones HM, Mulligan RS, Acton PD, Visvikis D, Ell PJ, Kerwin RW, Pilowsky LS (2000) Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography (SPET) study. Br J Psychiatry 177: 408–415

    Article  CAS  PubMed  Google Scholar 

  12. van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA (1997) Clozapine versus placebo in Huntington’s disease: a double blind randomised comparative study. J Neurol Neurosurg Psychiatry 63: 35–39

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raphael M. Bonelli MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonelli, R.M., Niederwieser, G. Quetiapine in Huntington’s disease: a first case report. J Neurol 249, 1114–1115 (2002). https://doi.org/10.1007/s00415-002-0741-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-002-0741-1

Keywords

Navigation